^
BIOMARKER:

MET exon 14 mutation

i
Other names: DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase




Show legend

Include preclinical:
Non Small Cell Lung Cancer
Lung Adenocarcinoma
Gastric Cancer
Biliary Tract Cancer
Solid Tumor
tepotinib
crizotinib
cabozantinib tablet
capmatinib
savolitinib
REGN5093
BPI-9016M
amivantamab-vmjw
ABN401
SCC244
nivolumab
CKD-702
DO-1
tepotinib + capmatinib
pembrolizumab
APL-101
ensartinib
GB263T
KC1036
durvalumab
S95027
PD1 inhibitor
c-MET inhibitor
c-MET inhibitor + Tyrosine kinase inhibitor
Immunotherapy